Eli Lilly and Company

Vice President (or Associate Vice President), Biomarker Development for Neuroscience pipeline

Sweden

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Job Description

Employment Type: Full time

About Lilly

At Lilly, we unite caring with discovery to make life better for people around the world. Headquartered in Indianapolis, Indiana, we are a global healthcare leader with over 35,000 employees dedicated to discovering and delivering life-changing medicines. Our mission extends beyond pharmaceuticals—we are committed to improving disease management, fostering scientific innovation, and giving back to communities through philanthropy and volunteerism.

Position Overview

Lilly’s Neuroscience Research team is at the forefront of developing cutting-edge therapies and diagnostics for brain disorders. We seek an accomplished biomarker expert to lead our efforts in biomarker discovery and validation, enabling the diagnosis and treatment of neurodegenerative conditions. As Vice President (or Associate Vice President), you will drive the strategic and technical development of biomarker assays that are instrumental in the advancement of our neuroscience pipeline. Biomarkers play a crucial role in clinical trials, providing insights into patient selection, therapeutic efficacy, safety, and mechanisms of action.

Key Responsibilities

  • Lead the development and validation of novel biomarker assays for early- and late-phase clinical trials in neurodegenerative diseases, including Alzheimer’s, Parkinson’s, ALS, and rare brain disorders.
  • Oversee teams of biomarker researchers at Lilly’s laboratories in Boston and Indianapolis, focusing on immunoassay- and mass spectrometry-based assay development.
  • Serve as a scientific and technical expert for in-house and outsourced biomarker discovery efforts, guiding experimental study design and analytical strategies.
  • Collaborate cross-functionally with internal stakeholders (medical, operations, statistics, regulatory) and external partners (CROs, academic institutions) to ensure biomarker validation and successful integration into clinical programs.
  • Communicate findings through presentations, publications, and strategic discussions, reinforcing Lilly’s leadership in biomarker innovation.

Basic Qualifications

  • PhD in Neuroscience or a related field.
  • 5+ years of experience in biomarker development, with recognized expertise in immunoassay- and mass spectrometry-based assays for brain diseases.

Preferred Skills & Experience

  • Proven leadership in managing and mentoring biomarker research teams in academic or industry settings.
  • Deep understanding of assay development, validation, and regulatory requirements for biomarker applications in clinical trials.
  • Strong strategic thinking, problem-solving abilities, and the ability to drive innovation in biomarker discovery.
  • Excellent communication, collaboration, and negotiation skills to influence both internal and external stakeholders.
  • Demonstrated ability to translate scientific insights into impactful clinical applications.

Join Lilly in shaping the future of neuroscience by advancing biomarker-driven precision medicine. If you are a leader in biomarker discovery looking to make a meaningful impact, we invite you to apply.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form.

Skills

Biomarker Discovery
Biomarker Validation
Neuroscience
Alzheimer's Disease
Parkinson's Disease
ALS
Clinical Trials
Assay Development
Leadership
Strategic Development
Technical Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI